A Randomized Controlled Trial of Advanced Colorectal Cancer with Fuzheng Jiedu Prescription Combined with Chemotherapy

Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients meeting the above diagnostic criteria;
•Two Patients with stage IV colorectal cancer according to TNM stage; X-ray, CT, CEA value and other tumor observation indicators available for observation: there is at least one evaluable lesion (measurable or unmeasurable lesion), if the lesion that has received local treatment (radiotherapy, ablation, vascular intervention, etc.) is the only lesion, then the lesion must have imaging basis for clear disease progression; the occurrence of the same disease Temporal metastasis;
•3. For patients with Karnofsky score >= 60, ECoG score <= 1;
•4. Patients over 18 years old;
•5. Patients with an expected survival period of more than 3 months;
•6. Patients who voluntarily participated in this study were followed up with informed consent.

•1. Patients with severe infection;
•2. Patients with severe hypertension, coronary heart disease, cardiac insufficiency, liver and kidney or marrow dysfunction;
•3. Women with history of mental illness or pregnancy;
•4. Patients who have participated in clinical trials of other drugs or medical devices in recent one month.

发起方

Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine